Skip to main content
Log in

Prognostic Significance of Anatomic Origin and Evaluation of Survival Statistics of Astrocytoma Patients—a Tertiary Experience

  • Original Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Astrocytoma constitutes the most noted malignancies of the central nervous system with worse clinical outcomes in grade IV astrocytoma or glioblastoma multiforme. Owing to poor clinical outcomes with existing therapeutic regime, there is a need to revisit the initial course of treatment. Statistical information of clinicopathological parameters could be used to understand the spread of disease and, in turn, to formulate updated treatment management. In the present study, we have seen anatomic distribution of astrocytoma subtypes in a group of 479 patients and correlated it with survival outcomes. Anatomic location was confirmed by MRI (magnetic resonance imaging) images. A registry of patients was maintained with clinicopathological details as tumor type, location, age/sex, and survival after surgery. We have observed overall survival particulars in patients diagnosed with astrocytoma. Our findings highlight that in total cases, tumor location was anatomically dominated by frontal and temporal lobes. Survival analysis in high-grade (grade III, p = 0.03; grade IV, p = 0.01) astrocytic tumors confirms poor outcomes with temporal, parietal, and occipital location as compared to frontal lobe. Overall survival study demonstrates glioblastoma multiforme (GBM) was associated with worse prognosis as compared to astrocytoma subtypes (p < 0.0001). In high-grade astrocytomas, anaplastic astrocytoma was found with 34 months of median survival age while 14 months in the case of patients with glioblastoma multiforme. In conclusion, we report dismal prognosis in parietal, temporal, and occipital lobes in grade II, grade III, and grade IV astrocytoma patients. Among astrocytoma subtypes, patients with glioblastoma multiforme were associated with worse survival outcomes. We uniquely feature the survival of astrocytoma patients for the first time and observe GBM patients have slightly longer survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109. https://doi.org/10.1007/s00401-007-0243-4

    Article  PubMed  PubMed Central  Google Scholar 

  2. Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro-Oncology 14(Suppl 5):v1–v49. https://doi.org/10.1093/neuonc/nos218

  3. Baldi I, Gruber A, Alioum A, Berteaud E, Lebailly P, Huchet A, Tourdias T, Kantor G, Maire JP, Vital A, Loiseau H, and the Gironde TSNC Registry Group, Champeaux K, Dhauteribes M, Eimer S, Gimbert E, Liguoro D, Monteil P, Penchet G, San-Galli F, Vignes J (2011) Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000-2007. Neuro-Oncology 13(12):1370–1378. https://doi.org/10.1093/neuonc/nor120

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. van den Bent MJ, Bromberg JE (2015) Neuro-oncology: the many challenges of treating elderly glioblastoma patients. Nat Rev Neurol 11(7):374–375. https://doi.org/10.1038/nrneurol.2015.82

    Article  CAS  PubMed  Google Scholar 

  5. Walid MS (2008) Prognostic factors for long-term survival after glioblastoma. Perm J 12(4):45–48

    Article  PubMed  PubMed Central  Google Scholar 

  6. Lamborn KR, Chang SM, Prados MD (2004) Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro-Oncology 6(3):227–235

    Article  PubMed  PubMed Central  Google Scholar 

  7. Deshpande RP, Babu D, Panigrahi M, Chandra Sekhar YB, Prakash Babu P (2016) Brain tumors incidences and a retrospective clinical analysis from a tertiary hospital in India. J Neuro-Oncol 129(2):383–387. https://doi.org/10.1007/s11060-016-2183-0

    Article  Google Scholar 

  8. Homma T, Fukushima T, Vaccarella S, Yonekawa Y, Di Patre PL, Franceschi S et al (2006) Correlation among pathology, genotype, and patient outcomes in glioblastoma. J Neuropathol Exp Neurol 65(9):846–854

    Article  CAS  PubMed  Google Scholar 

  9. Kraus JA, Glesmann N, Beck M, Krex D, Klockgether T, Schackert G, Schlegel U (2000) Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme. J Neuro-Oncol 48(2):89–94

    Article  CAS  Google Scholar 

  10. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro-Oncology 4(4):278–299

    Article  PubMed  PubMed Central  Google Scholar 

  11. Peters O, Gnekow AK, Rating D, Wolff JE (2004) Impact of location on outcome in children with low-grade oligodendroglioma. Pediatr Blood Cancer 43(3):250–256. https://doi.org/10.1002/pbc.20111

    Article  PubMed  Google Scholar 

  12. Jeremic B, Grujicic D, Antunovic V, Djuric L, Stojanovic M, Shibamoto Y (1994) Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach. J Neuro-Oncol 21(2):177–185

    Article  CAS  Google Scholar 

  13. Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, Isaacson S, Rotman M, Asbell SO, Nelson JS, Weinstein AS, Nelson DF (1993) Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 26(2):239–244

    Article  CAS  PubMed  Google Scholar 

  14. Duffau H, Capelle L (2004) Preferential brain locations of low-grade gliomas. Cancer 100(12):2622–2626. https://doi.org/10.1002/cncr.20297

    Article  PubMed  Google Scholar 

  15. Larjavaara S, Mantyla R, Salminen T, Haapasalo H, Raitanen J, Jaaskelainen J et al (2007) Incidence of gliomas by anatomic location. Neuro-Oncology 9(3):319–325. https://doi.org/10.1215/15228517-2007-016

    Article  PubMed  PubMed Central  Google Scholar 

  16. Laigle-Donadey F, Martin-Duverneuil N, Lejeune J, Criniere E, Capelle L, Duffau H, Cornu P, Broet P, Kujas M, Mokhtari K, Carpentier A, Sanson M, Hoang-Xuan K, Thillet J, Delattre JY (2004) Correlations between molecular profile and radiologic pattern in oligodendroglial tumors. Neurology 63(12):2360–2362

    Article  CAS  PubMed  Google Scholar 

  17. Mueller W, Hartmann C, Hoffmann A, Lanksch W, Kiwit J, Tonn J, Veelken J, Schramm J, Weller M, Wiestler OD, Louis DN, von Deimling A (2002) Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets. Am J Pathol 161(1):313–319. https://doi.org/10.1016/S0002-9440(10)64183-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Zlatescu MC, TehraniYazdi A, Sasaki H, Megyesi JF, Betensky RA, Louis DN, Cairncross JG (2001) Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Res 61(18):6713–6715

    CAS  PubMed  Google Scholar 

  19. Ali Kahn A, O'Brien DF, Kelly P, Phillips JP, Rawluk D, Bolger C, Pidgeon CN (2003) The anatomical distribution of cerebral gliomas in mobile phone users. Ir Med J 96(8):240–242

    CAS  PubMed  Google Scholar 

  20. Liu TT, Achrol AS, Mitchell LA, Du WA, Loya JJ, Rodriguez SA et al (2016) Computational identification of tumor anatomic location associated with survival in 2 large cohorts of human primary glioblastomas. AJNR Am J Neuroradiol 37(4):621–628. https://doi.org/10.3174/ajnr.A4631.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Sanai N, Berger MS (2008) Glioma extent of resection and its impact on patient outcome. Neurosurgery 62(4):753–764; discussion 264-6. https://doi.org/10.1227/01.neu.0000318159.21731.cf

    Article  PubMed  Google Scholar 

  22. Colen RR, Vangel M, Wang J, Gutman DA, Hwang SN, Wintermark M et al (2014) Imaging genomic mapping of an invasive MRI phenotype predicts patient outcome and metabolic dysfunction: a TCGA glioma phenotype research group project. BMC Med Genet 7:30. https://doi.org/10.1186/1755-8794-7-30

    Article  CAS  Google Scholar 

  23. Lim DA, Cha S, Mayo MC, Chen MH, Keles E, VandenBerg S, Berger MS (2007) Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro-Oncology 9(4):424–429. https://doi.org/10.1215/15228517-2007-023

    Article  PubMed  PubMed Central  Google Scholar 

  24. Ostrom QT, Gittleman H, Kruchko C, Louis DN, Brat DJ, Gilbert MR, Petkov VI, Barnholtz-Sloan JS (2016) Completeness of required site-specific factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004-2012, varying). J Neuro-Oncol 130(1):31–42. https://doi.org/10.1007/s11060-016-2217-7

    Article  Google Scholar 

Download references

Acknowledgements

The authors acknowledge KFRC, KIMS for the ethical permission and for diagnosis and histopathology of tissues, and Dr. M. Sailaja, Head, Department of Pathology.

Funding

The authors thank the financial assistance from the Department of Science and Technology (DST-India) (Grant no. SB/EMEQ-257/2013, SR/CSRI/196/2016), the Department of Biotechnology (DBT-India) (Grant no. BT/PR18168/MED/29/1064/2016, BT/PR13111/MED/29/149/2009), and the University with Potential for Excellence (UPE-India) (Grant no. UH/UGC/UPE-2/Interface studies/ Research Projects/B1.4, UH/UPE-2/28/2015) for lab funding. RDP is thankful to the Department of Biotechnology (DBT-India) (Award no. DBT JRF/2011–12/95) for student fellowship.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Phanithi Prakash Babu.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

The present studies involving human participants were approved by the Institutional Ethics Committee (ICE), University of Hyderabad and KIMS Foundation Research Centre (KFRC), KIMS, Secunderabad, India. All subjects participating were completely anonymized.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Deshpande, R.P., Y. B. V. K., C., Panigrahi, M. et al. Prognostic Significance of Anatomic Origin and Evaluation of Survival Statistics of Astrocytoma Patients—a Tertiary Experience. Indian J Surg Oncol 10, 55–60 (2019). https://doi.org/10.1007/s13193-018-0820-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-018-0820-0

Keywords

Navigation